Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: Insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries

被引:30
作者
Yan, Bryan P. [3 ,4 ]
Clark, David J. [5 ]
Buxton, Brian [8 ]
Ajani, Andrew E. [2 ,6 ]
Smith, Julian A. [9 ]
Duffy, Stephen J. [7 ]
Shardey, Gil C. [9 ]
Skillington, Peter D. [10 ]
Farouque, Omar [5 ]
Yii, Michael [11 ]
Yap, Cheng-Hon [10 ]
Andrianopoulos, Nick
Brennan, Angela
Dinh, Diem
Reid, Christopher M. [1 ]
机构
[1] Monash Univ, NHMRC Ctr Clin Res Excellence Therapeut, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia
[2] Univ Melbourne, Melbourne, Vic, Australia
[3] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA
[4] Harvard Univ, Sch Med, Boston, MA USA
[5] Dept Cardiol, Austin, Australia
[6] Dept Cardiol, Royal Melbourne, Vic, Australia
[7] Alfred Hosp, Dept Cardiol, Melbourne, Vic, Australia
[8] Dept Cardiothorac Surg, Austin, Australia
[9] Monash Med Ctr, Dept Cardiothorac Surg, Melbourne, Vic, Australia
[10] Dept Cardiothorac Surg, Royal Melbourne, Vic, Australia
[11] St Vincent Hosp, Dept Cardiothorac Surg, Melbourne, Vic, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
Coronary artery bypass surgery; Percutaneous coronary intervention; SIROLIMUS-ELUTING STENTS; TRIALS; OUTCOMES;
D O I
10.1016/j.hlc.2008.10.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Controversy continues over the optimal revascularisation strategy for patients with multi-vessel coronary artery disease. Clinical characteristics, risk profile, and mortality of patients undergoing coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) are thought to differ but there are limited contemporary comparative data. Methods: We compared clinical characteristics, in-hospital and 30-day mortality of 3841 consecutive patients undergoing isolated CABG and 4417 undergoing PCI. Independent predictors of 30-day mortality were determined by multiple logistic regression analysis. Results: CABG patients were older (p < 0.01). The CABG group had a higher incidence of diabetes, heart failure, left ventricular ejection fraction <45%, multi-vessel coronary artery, peripheral vascular and cerebro-vascular disease (all p < 0.01). Patients undergoing PCI had a higher incidence of recent myocardial infarction (MI) as the indication for revascularisation (p < 0.01). In-hospital and 30-day mortality was 1.8% and 1.7% in the CABG group, and 1.4% and 1.8% in the PCI group, respectively. Independent predictors of 30-day mortality after CABG were age (odds ratio 1.1 per year, 950% confidence interval 1.0-1.1), cardiogenic shock (4.10, 1.7-10.5) and previous CABG (6.6, 2.4-17.7). Predictors after PCI were diabetes (2.7, 1.4-5.1), female gender (3.0, 1.6-5.5), renal failure (3.2, 1.2-8.0), MI < 24h (4.0, 2.2-7.6), left main intervention (5.4, 1.0-27.7), heart failure (6.0, 2.6-14.0) and cardiogenic shock (11.7, 5.4-25.2). Conclusions: In contemporary clinical practice, CABG is preferred in patients with multi-vessel coronary and associated non-coronary vascular disease, while PCI is the dominant strategy for acute MI. Despite this, in-hospital and 30-day mortality rates were similar. Predictors of early mortality after CABG differ to those of PCI. (Heart, Lung and Circulation 2009;18:184-190) (C) 2008 Australasian Society of Cardiac and Thoracic Surgeons and the Cardiac Society of Australia and New Zealand. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:184 / 190
页数:7
相关论文
共 16 条
[1]  
Ajani A E, 2006, Heart Lung Circ, V15, P44, DOI 10.1016/j.hlc.2005.08.001
[2]  
Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002
[3]   A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents [J].
Babapulle, MN ;
Joseph, L ;
Bélisle, P ;
Brophy, JM ;
Eisenberg, MJ .
LANCET, 2004, 364 (9434) :583-591
[4]   Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era [J].
Hannan, Edward L. ;
Racz, Michael ;
Holmes, David R. ;
King, Spencer B., III ;
Walford, Gary ;
Ambrose, John A. ;
Sharma, Samin ;
Katz, Stanley ;
Clark, Luther T. ;
Jones, Robert H. .
CIRCULATION, 2006, 113 (20) :2406-2412
[5]   Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents [J].
Iakovou, I ;
Schmidt, T ;
Bonizzoni, E ;
Ge, L ;
Sangiorgi, GM ;
Stankovic, G ;
Airoldi, F ;
Chieffo, A ;
Montorfano, M ;
Carlino, M ;
Michev, I ;
Corvaja, N ;
Briguori, C ;
Gerckens, U ;
Grube, E ;
Colombo, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (17) :2126-2130
[6]   Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents [J].
Kastrati, Adnan ;
Mehilli, Julinda ;
Pache, Juergen ;
Kaiser, Christoph ;
Valgimigli, Marco ;
Kelbaek, Henning ;
Menichelli, Maurizio ;
Sabate, Manel ;
Suttorp, Maarten J. ;
Baumgart, Dietrich ;
Seyfarth, Melchior ;
Pfisterer, Matthias E. ;
Schoemig, Albert .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (10) :1030-1039
[7]   Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials [J].
Keeley, EC ;
Boura, JA ;
Grines, CL .
LANCET, 2003, 361 (9351) :13-20
[8]   Appropriate timing of surgical intervention after transmural acute myocardial infarction [J].
Lee, DC ;
Oz, MC ;
Weinberg, AD ;
Ting, W .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 125 (01) :115-120
[9]   Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery [J].
Moses, JW ;
Leon, MB ;
Popma, JJ ;
Fitzgerald, PJ ;
Holmes, DR ;
O'Shaughnessy, C ;
Caputo, RP ;
Kereiakes, DJ ;
Williams, DO ;
Teirstein, PS ;
Jaeger, JL ;
Kuntz, RE .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (14) :1315-1323
[10]  
REID CM, 2002, HEART LUNG CIRC, V13, P291